1921
Volume 77, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

To elucidate determinants of morbidity in schistosomiasis mansoni, a community-based study was undertaken involving 2,451 subjects (mean age, 18.8 ± 15.3 [SD] years) from four endemic sites in Ethiopia. Overall prevalence of infection was 65.9%, reported blood in stools was 35.8%, and schistosomal periportal thickening/fibrosis (PPT/F) was 4.6%. Similarly, 43.2% were positive for at least one marker of hepatitis B virus (HBV), 5.3% were HBsAg positive, and 1.3% were anti-hepatitis C virus (HCV) positive. Prevalence of PPT/F increased significantly with increasing community prevalence and intensity of infection. In a multiple logistic regression analysis, intensity of egg excretion, markers of HBV infection, age, and male sex were significantly associated with PPT/F, whereas co-infection with other intestinal helminths was associated with lower odds for PPT/F. HCV was not associated with infection or with schistosomal PPT/F. In conclusion, integrated helminth control targeting school-aged children, who have the highest burden infection, should be used to substantially reduce the risk of periportal fibrosis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.77.1079
2007-12-01
2017-09-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/77/6/0771079.html?itemId=/content/journals/10.4269/ajtmh.2007.77.1079&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2002. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis. Geneva: World Health Organization.
  2. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D, 2003. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86 : 125–139.
  3. Blanton RE, Abdel-Salam E, Kariuki HC, Magak P, Silva LK, Muchiri EM, Thiongo F, Abdel-Meghid IE, Butterworth AE, Reis MG, Ouma JH, 2002. Population based differences in schistosomiasis mansoni-and Hepatitis C-induced disease. J Infect Dis 185 : 1644–1649.
  4. King CH, Magak P, Abdel-Salam E, Ouma JH, Kariuki HC, Blanton RE, 2003. Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health 8 : 109–117.
  5. Homeida M, Ahmed S, Dafalla A, Suliman S, Eltom I, Nash T, Bennett JL, 1988. Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 39 : 196–201.
  6. Mohamed-Ali Q, Elwali NE, Abdelhameed AA, Mergani A, Rahoud S, Elagib KE, Saeed OK, Abel L, Magzoub MM, Dessein AJ, 1999. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis 180 : 1298–1306.
  7. Kardorff R, Traore M, Diarra A, Sacko M, Maiga M, Franke D, Vester U, Hansen U, Traore HA, Fongoro S, Gorgen H, Korte R, Gryseels B, Doehring-Schwerdfeger E, Ehrich JHH, 1994. Lack of ultrasonographic evidence for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali. Am J Trop Med Hyg 51 : 190–197.
  8. Booth M, Vennervald BJ, Kabatereine NB, Kazibwe F, Ouma JH, Kariuki CH, Muchiri E, Kadzo H, Ireri E, Kimani G, Mwatha JK, Dunn DW, 2004. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but with very different duration of residence. Trans R Soc Trop Med Hyg 98 : 125–136.
  9. Boisier P, Ramarokoto CE, Ravoniarimbinina P, Rabarijaona L, Ravaoalimalala VE, 2001. Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity. Trop Med Int Health 6 : 699–706.
  10. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, Nenri S, Abdelhameed AA, Saeed OK, Magzoub MM, Abel L, 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65 : 709–721.
  11. Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, Argiro L, Rahoud S, Mergani A, Henri S, Gaudart J, Mohamed-Ali Q, Young HA, Dessein AJ, 2003. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 171 : 5596–5601.
  12. Kariuki HC, Mbugua G, Magak P, Bailey JA, Muchiri EM, Thiongo FW, King CH, Butterworth AE, Ouma JH, Blanton RE, 2001. Prevalence and familial aggregation of schistosomal liver morbidity in Kenya: evaluation by new ultrasound criteria. J Infect Dis 183 : 960–966.
  13. Hiatt RA, 1976. Morbidity from schistosoma mansoni infections: an epidemiologic study based on quantitative analysis of egg excretion in two highland Ethiopian villages. Am J Trop Med Hyg 25 : 808–817.
  14. Hiatt RA, Gebre-Medhin M, 1977. Morbidity from Schistosoma mansoni infections: an epidemiologic study based on quantitative analysis of egg excretion in Ethiopian children. Am J Trop Med Hyg 26 : 473–481.
  15. Peters PA, El Alamy M, Warren KS, Mahmoud AA, 1980. Quick Kato smear for field quantitation of Schistosoma mansoni eggs. Am J Trop Med Hyg 29 : 217–219.
  16. Berhe N, Medhin G, Erko B, Smith T, Gedamu S, Bereded D, Moore R, Habte E, Redda A, Gebre-Michael T, Gundersen SG, 2004. Variations in helminth faecal egg counts in Kato-Katz thick smears and their implications in assessing infection status with Schistosoma mansoni. Acta Trop 92 : 205–212.
  17. Berhe N, Geitung JT, Medhin G, Gundersen SG, 2006. Large scale evaluation of WHO’s ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia. Trop Med Int Health 11 : 1286–1294.
  18. World Health Organization, 2000. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity. Available at http://www.who.int/tdr/publications/publications/pdf/ultrasound.pdf. Accessed January 20, 2007.
  19. Kardorff R, Gabone RM, Mugashe C, Obiga D, Ramarokato CE, Mahlert C, Spannbrucker N, Lang A, Gunzler V, Gryseels B, Ehrich JH, Doehring E, 1997. Schistosoma mansoni related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters. Trop Med Int Health 2 : 230–239.
  20. Tsega E, Mengesha B, Hansson BG, Lindberg J, Nordenfelt E, 1986. Hepatitis, A, B, and delta infection in Ethiopia: a serological survey with demographic data. Am J Epidemiol 123 : 344–350.
  21. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT, 2003. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 131 : 757–770.
  22. Kefene H, Rapicetta M, Rossi GB, Bisanti L, Bekura D, Morace G, Palladine P, Di Rienza A, Conti S, Bassani F, 1988. Ethiopian National Hepatitis B Study. J Med Virol 24 : 75–84.
  23. Gebreselassie L, 1986. Occurrence of hepatitis B surface antigen in various population groups in Ethiopia. Ethiop Med J 24 : 63–67.
  24. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F, 1993. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 49 : 435–439.
  25. Ayele W, Nokes DJ, Abebe A, Messele T, Dejene A, Enquselassie F, Rinke de Wit TF, Fontanet AL, 2002. Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol 68 : 12–17.
  26. Hammad HA, el Fattah MM, Moris M, Madina EH, el Abbasy AA, Soliman AT, 1990. Study on some hepatic functions and prevalence of hepatitis B surface antigenaemia in Egyptian children with schistosomal hepatic fibrosis. J Trop Pediatr 36 : 126–127.
  27. Ghaffar YA, Fattah SA, Kamel M, Badr RM, Mahomed FF, Strickland GT, 1991. The impact of endemic schistosomiasis on acute viral hepatitis. Am J Trop Med Hyg 45 : 743–750.
  28. Badawi AF, Michael MS, 1999. Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis B viral infection and schistosomias. Anticancer Res 19 : 4565–4569.
  29. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R, 1993. Risk factors associated with a high sero-prevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49 : 440–447.
  30. Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW, 2000. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20 : 281–289.
  31. Mohamed A, Elisheikh A, Ghandour Z, Al-Karawi M, 1998. Impact of hepatitis C virus infection on schistosomal liver disease. Hepatogastroenterology 45 : 1492–1496.
  32. Pereira LMMB, Melo MCV, Lacerda C, Spinelli V, Domingues ALC, Massarolo P, Mies S, Saleh MG, McFarlane IG, Williams R, 1994. Hepatitis B infection in schistosomiasis mansoni. J Med Virol 42 : 203–206.
  33. Pereira LMMB, Melo MCV, Saleh MG, Massarolo P, Koskinas J, Domingues ALC, Spinelli V, Mies S, Williams R, McFarlane IG, 1995. Hepatitis C virus infection in Schistosomiasis mansoni in Brazil. J Med Virol 45 : 423–428.
  34. El-Sayed HF, Abaza SM, Mehanna S, Winch PJ, 1997. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta Trop 68 : 229–237.
  35. Eltoum IA, Ghalib HW, Abdel-Gadir AF, Suliaman SM, Homeida MM, 1991. Lack of association between schistosomiasis and hepatitis B virus infection in Gezira-Managil area, Sudan. Trans R Soc Trop Med Hyg 85 : 81–82.
  36. Kamel MA, Miller FD, el Masry AG, Zakaria S, Khattab M, Essmat G, Ghaffar YA, 1994. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 88 : 501–509.
  37. Mudawi HMY, Smith HM, Rahoud SA, Fletcher IA, Babikir AM, Saeed OK, Fedail S, 2007. Epidemiology of HCV infection in Gezira state of central Sudan. J Med Virol 79 : 383–385.
  38. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby R, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I, 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 : 887–891.
  39. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Anwar W, Strickland GT, Fix AD, Sallam I, 2001. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33 : 248–253.
  40. Cox FEG, 2001. Concomitant infections, parasites and immune response. Parasitology 122 (Suppl): S23–S38.
  41. Brutus L, Watier L, Briand V, Hanitrasoamampionona V, Razanatsoarilala H, Cot M, 2006. Parasitic co-infections: does Ascaris lumbricoides protect against Plasmodium falciparum infection? Am J Trop Med Hyg 75 : 194–198.
  42. Nacher M, Singhasivanon P, Traore B, Vannaphan S, Gay F, Chindanond D, Franetich JF, Mazier D, Looareesuwan S, 2002. Helminth infections are associated with protection from cerebral malaria and increased nitrogen derivatives concentrations in Thailand. Am J Trop Med Hyg 66 : 304–309.
  43. Druile P, Tall A, Sokhna C, 2005. Worms can worsen malaria: towards a new means to roll back malaria. Trends Parasitol 21 : 359–362.
  44. Berhe N, Halvorsen BL, Gundersen TE, Myrvang B, Gundersen SG, Blomhoff R, 2007. Reduced serum concentrations of retinol α-tocopherol and high concentrations of hydroperoxides are associated with community levels of S. mansoni infection and schistosomal periportal fibrosis in Ethiopian schoolchildren. Am J Trop Med Hyg 76 : 943–949.
  45. Medhat A, Nefeh M, Swifee Y, Helmy A, Zaki S, Shehata M, Ibrahim S, Abdel-Kader DA, Strickland GT, 1998. Ultrasound-detected hepatic periportal thickening in patients with prolonged pyrexia. Am J Trop Med Hyg 59 : 45–48.
  46. Sarin SK, Kapoor D, 2002. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 17 : 526–534.
  47. Gürkaynak G, Yildirim B, Aksoy F, Temucin G, 1998. Sonographic findings in non-cirrhotic portal fibrosis. J Clin Ultrasound 26 : 309–313.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.77.1079
Loading
/content/journals/10.4269/ajtmh.2007.77.1079
Loading

Data & Media loading...

  • Received : 02 May 2007
  • Accepted : 31 Aug 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error